Treatment for Deep Vein Thrombosis (DVT)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Deep Vein Thrombosis (DVT)
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new way to dissolve clots in people with DVT. They will compare it to the current standard of care and also look at the financial implications.

Eligible Conditions
  • Deep Vein Thrombosis (DVT)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 1 month

1 month
Post-thrombotic Syndrome (PTS) severity using the Villalta score

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

30 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 month

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
401 Previous Clinical Trials
158,339 Total Patients Enrolled
Penumbra Inc.Industry Sponsor
33 Previous Clinical Trials
8,535 Total Patients Enrolled
Aaron Rohr, MDPrincipal InvestigatorInterventional Radiology-Vascular

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have the ability to undergo thrombolysis in combination with Indigo endhole aspiration device.
You are at least 18 years old.
Onset of acute DVT occurred <14 days.